OTC Markets Group Welcomes Lexaria Bioscience Corp. to OTCQX

NEW YORK, Jan. 4, 2018 /PRNewswire/ -- OTC Markets Group Inc. OTCM, operator of financial markets for 10,000 U.S. and global securities, today announced Lexaria Bioscience Corp. LXRP, a drug delivery platform innovator, has qualified to trade on the OTCQX® Best Market.  Lexaria upgraded to OTCQX from the OTCQB® Venture Market.   

Lexaria begins trading today on OTCQX under the symbol "LXRP."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"Congratulations to Lexaria on graduating from our OTCQB Venture Market to trade on our OTCQX Best Market," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Trading on OTCQX will enable Lexaria to provide a transparent trading and information experience for investors as it focuses on growing its business and delivering long-term value to shareholders."

"Lexaria has made notable progress over the past twelve months in all aspects of its business, and will receive even more recognition by upgrading to OTCQX," said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. "Lexaria expects to provide greater visibility and liquidity for our investors on OTCQX as we build our disruptive technology innovations through 2018 and beyond."

Lexaria was sponsored for OTCQX by J.P. Galda & Co., a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership. 

About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October 2016. Lexaria's technology provides increases of up to 1 Ox in intestinal absorption rates; more rapid delivery to the bloodstream with effects often within 15-20 minutes; and important taste-masking benefits for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.

About OTC Markets Group Inc.
OTC Markets Group Inc. OTCM operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities.  Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS. Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com

View original content with multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-lexaria-bioscience-corp-to-otcqx-300577232.html

SOURCE OTC Markets Group Inc.